Caitong International Asset Management’s Vera Therapeutics VERA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$110K Buy
2,736
+2,719
+15,994% +$117K 0.02% 552
2025
Q4
$861 Sell
17
-215
-93% -$7.64K ﹤0.01% 1390
2025
Q3
$6.74K Buy
232
+122
+111% +$2.82K ﹤0.01% 1143
2025
Q2
$2.59K Buy
110
+74
+206% +$1.66K ﹤0.01% 1297
2025
Q1
$865 Buy
+36
New +$1.16K ﹤0.01% 1616

Other funds holding VERA

Caitong International Asset Management's VERA Position: Q1 2026 in Review

Caitong International Asset Management increased its Vera Therapeutics (VERA) stake by 15,994% in Q1 2026, buying an estimated $117K and bringing the position to 2,736 shares worth $110K. The position accounts for 0.02% of the portfolio, ranked #552.

Caitong International Asset Management first reported a position in VERA in Q1 2025 and has held it in 5 quarters since. 229 funds tracked by Wall St. Rank hold VERA as of Q1 2026.

  • Caitong International Asset Management held 2,736 shares of Vera Therapeutics worth $110K as of Q1 2026.
  • Caitong International Asset Management bought 2,719 Vera Therapeutics shares in Q1 2026, an estimated $117K.
  • Vera Therapeutics made up 0.02% of Caitong International Asset Management's portfolio in Q1 2026, its #552 holding.
  • Caitong International Asset Management first reported a position in Vera Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • 229 funds tracked by Wall St. Rank held Vera Therapeutics as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.